Daniel O'Day has replaced Heiner Dreismann as head of Roche Molecular Diagnostics, Roche said last week. O'Day most recently served as head of operations for Roche Pharmaceuticals in Denmark.
As head of Roche Molecular Diagnostics, O'Day will be responsible for all global functions including research, development, manufacturing, and marketing, as well as site operations in Pleasanton and Alameda, Calif.; Branchburg and Belleville, NJ; and Penzberg, Germany.
O'Day holds a BS in biology from Georgetown University and an MBA from Columbia University.
Applied Biosystems last week launched its TargetSeq Resequencing System, which is intended for resequencing smaller genomes and targeted genomic regions using the company's 3730 and 3730xl DNA Analyzers. The TargetSeq system includes a software module for sequencing small DNA stretches of 200 to 400 bases in 20 minutes or less, the company said. The system increases the number of bases read by the 3730 Analyzer to more than 2.8 megabases per day, the company added.
CombiMatrix this week launched upgraded versions of its CustomArray and CustomArray Synthesizer that enable users to synthesize the firm's CustomArray 90K, an array that can contain up to 94,000 features.